Eagle Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $303K | Sell |
11,201
-252,383
| -96% | -$6.84M | ﹤0.01% | 520 |
|
|
2024
Q2 | $6.64M | Sell |
263,584
-46,575
| -15% | -$1.17M | 0.04% | 360 |
|
|
2024
Q1 | $9.3M | Buy |
310,159
+91,060
| +42% | +$2.73M | 0.05% | 298 |
|
|
2023
Q4 | $8.85M | Buy |
+219,099
| New | +$8.85M | 0.05% | 288 |
|
|
2022
Q1 | – | Sell |
-265,607
| Closed | -$3.86M | – | 580 |
|
|
2021
Q4 | $3.86M | Sell |
265,607
-121,109
| -31% | -$1.76M | 0.02% | 435 |
|
|
2021
Q3 | $18.1M | Sell |
386,716
-119,233
| -24% | -$5.59M | 0.08% | 229 |
|
|
2021
Q2 | $30.8M | Sell |
505,949
-17,744
| -3% | -$1.08M | 0.13% | 199 |
|
|
2021
Q1 | $31.1M | Buy |
523,693
+177,693
| +51% | +$10.5M | 0.14% | 201 |
|
|
2020
Q4 | $24.6M | Buy |
+346,000
| New | +$24.6M | 0.14% | 206 |
|